TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 22
2.1.2.2 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 23
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION 25
2.3 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 PEN NEEDLES MARKET OVERVIEW 31
4.2 EUROPE: PEN NEEDLES MARKET, BY TYPE & COUNTRY, 2018 32
4.3 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2018 33
4.4 PEN NEEDLES MARKET: GEOGRAPHIC SNAPSHOT 34
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Growing prevalence of chronic diseases 36
5.2.1.2 Favorable reimbursement in selected countries 36
5.2.2 RESTRAINTS 36
5.2.2.1 Preference for alternative modes of drug delivery 36
5.2.2.2 Poor reimbursement scenario in developing countries 37
 
5.2.3 OPPORTUNITIES 37
5.2.3.1 Growing preference for biosimilar drugs 37
5.2.4 CHALLENGES 38
5.2.4.1 Reuse of pen needles 38
6 INDUSTRY INSIGHTS 39
6.1 INTRODUCTION 39
6.2 PORTER’S FIVE FORCES ANALYSIS 39
6.2.1 THREAT OF NEW ENTRANTS 40
6.2.2 BARGAINING POWER OF SUPPLIERS 40
6.2.3 BARGAINING POWER OF BUYERS 40
6.2.4 SEGMENT RIVALRY 40
6.2.5 THREAT OF SUBSTITUTES 41
6.3 COMPETITIVE INTENSITY 41
6.3.1 EVALUATION PARAMETERS 41
6.3.2 SCORING METHODOLOGY 43
6.3.3 COMPETITIVE INTENSITY SCORE, BY COMPANY 43
6.3.3.1 Competitive intensity score for BD 43
6.3.3.2 Competitive intensity score for Novo Nordisk 45
6.3.3.3 Competitive intensity score for Ypsomed 47
6.3.4 COMPETITIVE INTENSITY MAPPING OF BD, NOVO NORDISK, AND YPSOMED 49
6.3.5 COMPARISON OF EVALUATION PARAMETERS, BY COMPANY 51
6.3.5.1 Pricing 51
6.3.5.2 Product portfolio 51
6.3.5.3 Product launches/technological advancements 52
6.3.5.4 Geographical presence 53
6.3.5.5 Promotional/marketing activities 53
6.3.5.6 Sponsorships/Donations/Education/Awareness Campaigns 54
6.3.5.7 M&A, Partnerships, Collaborations, Agreements, and Expansions 54
6.3.5.8 Certifications/Accreditations/Awards 55
7 PEN NEEDLES MARKET, BY TYPE 56
7.1 INTRODUCTION 57
7.2 STANDARD PEN NEEDLES 58
7.2.1 STANDARD PEN NEEDLES ARE PREFERRED OVER SAFETY PEN NEEDLES AS THEY ARE MORE AFFORDABLE, CONSIDERING THE NEED FOR DAILY INSULIN INTAKE 58
7.3 SAFETY PEN NEEDLES 60
7.3.1 DEMAND FOR SAFETY PEN NEEDLES TO RISE DUE TO GROWING CONCERNS REGARDING THE PREVENTION OF NSIS ASSOCIATED WITH STANDARD NEEDLES 60
 
8 PEN NEEDLES MARKET, BY LENGTH 62
8.1 INTRODUCTION 63
8.2 4MM 64
8.2.1 4MM PEN NEEDLES ARE EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 64
8.3 5MM 64
8.3.1 5MM PEN NEEDLES TO REGISTER THE SECOND-HIGHEST GROWTH RATE DURING THE STUDY PERIOD 64
8.4 6MM 65
8.4.1 6MM PEN NEEDLES ARE THE MOST COMMONLY USED NEEDLES ACROSS THE GLOBE 65
8.5 8MM 65
8.5.1 8MM PEN NEEDLES WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 65
8.6 10MM 66
8.6.1 AVAILABILITY OF SHORTER PEN NEEDLES TO RESTRAIN THE GROWTH OF THE 10MM PEN NEEDLES MARKET 66
8.7 12MM 67
8.7.1 POPULARITY OF SHORTER & LESS PAINFUL NEEDLES TO HAMPER THE GROWTH OF THE 12MM PEN NEEDLES MARKET 67
9 PEN NEEDLES MARKET, BY THERAPY 68
9.1 INTRODUCTION 69
9.2 INSULIN THERAPY 70
9.2.1 RISING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET FOR INSULIN THERAPY 70
9.3 GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY 71
9.3.1 STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE GLP-1 DRUGS IN THE MARKET TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET FOR GLP-1 THERAPY 71
9.4 GROWTH HORMONE THERAPY 72
9.4.1 DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN THE GROWTH OF THE PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY 72
9.5 OTHER THERAPIES 73
10 PEN NEEDLES MARKET, BY MODE OF PURCHASE 75
10.1 INTRODUCTION 76
10.2 RETAIL 77
10.2.1 RETAIL PURCHASES OF PEN NEEDLES TO WITNESS HIGH GROWTH IN THE COMING YEARS OWING TO THE GROWING POPULARITY OF ONLINE PURCHASES 77
10.3 NON-RETAIL 78
10.3.1 THE LARGE NUMBER OF NEEDLE-PHOBIC DIABETIC PATIENTS IS SUPPORTING THE GROWTH OF THIS SEGMENT 78
11 PEN NEEDLES MARKET, BY REGION 80
11.1 INTRODUCTION 81
11.2 EUROPE 83
11.2.1 GERMANY 86
11.2.1.1 High diabetes expenditure and reimbursement for pen needles is expected to drive the market in Germany 86
11.2.2 UK 87
11.2.2.1 NHS support and access to cost-effective pen needles are likely to drive the market in the UK 87
11.2.3 FRANCE 88
11.2.3.1 Higher insurance coverage and increase in aging population and affordability contribute to demand for pen needles 88
11.2.4 ITALY 89
11.2.4.1 Wide regional variations in terms of benefits and coverage to slow growth in Italy 89
11.2.5 SPAIN 90
11.2.5.1 Supportive regulations mandating the use of safety pen needles to boost the growth of the Spanish market 90
11.2.6 REST OF EUROPE 91
11.3 NORTH AMERICA 92
11.3.1 US 95
11.3.1.1 US dominates the pen needles market in North America 95
11.3.2 CANADA 96
11.3.2.1 High diabetes prevalence and growing geriatric population will support pen needle uptake 96
11.4 ASIA PACIFIC 98
11.4.1 JAPAN 101
11.4.1.1 High diabetes incidence and approval of injectable insulin to drive the pen needles market in Japan 101
11.4.2 CHINA 102
11.4.2.1 Suboptimal insurance coverage policies will dampen market growth 102
11.4.3 INDIA 103
11.4.3.1 Low pen needle penetration, lack of awareness to restrain market growth in India 103
11.4.4 REST OF ASIA PACIFIC 104
11.5 REST OF THE WORLD 105
11.5.1 LATIN AMERICA 108
11.5.1.1 Healthcare reforms to drive growth in Mexico 108
11.5.2 MIDDLE EAST & AFRICA 109
11.5.2.1 Favorable reforms in South Africa to bolster market growth 109
 
12 COMPETITIVE LANDSCAPE 111
12.1 OVERVIEW 111
12.2 MARKET SHARE (AS OF 2017) 111
12.2.1 BECTON, DICKINSON AND COMPANY 112
12.2.2 NOVO NORDISK 112
12.2.3 YPSOMED 112
12.3 COMPETITIVE LEADERSHIP MAPPING (2017) 113
12.3.1 VENDOR INCLUSION CRITERIA 113
12.3.2 VISIONARY LEADERS 113
12.3.3 INNOVATORS 113
12.3.4 DYNAMIC DIFFERENTIATORS 113
12.3.5 EMERGING COMPANIES 114
12.4 COMPETITIVE SCENARIO 115
12.4.1 PRODUCT LAUNCHES 115
12.4.2 EXPANSIONS 116
12.4.3 AGREEMENTS 116
13 COMPANY PROFILES 117
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 BECTON, DICKINSON AND COMPANY 117
13.2 NOVO NORDISK 119
13.3 YPSOMED 121
13.4 OWEN MUMFORD, LTD. 123
13.5 HTL-STREFA 124
13.6 B. BRAUN MELSUNGEN 125
13.7 TERUMO CORPORATION 126
13.8 ULTIMED 128
13.9 ALLISON MEDICAL, INC. 129
13.10 ARTSANA S.P.A. 130
13.11 ARKRAY, INC. 131
13.12 GLUCORX 132

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX 133
14.1 DISCUSSION GUIDE 133
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 141
14.3 AVAILABLE CUSTOMIZATIONS 143
14.4 RELATED REPORTS 143
14.5 AUTHOR DETAILS 144

LIST OF TABLES

TABLE 1 EVALUATION PARAMETERS & SCORES 41
TABLE 2 COMPETITIVE INTENSITY FOR BD 43
TABLE 3 COMPETITIVE INTENSITY FOR NOVO NORDISK 45
TABLE 4 COMPETITIVE INTENSITY FOR YPSOMED 47
TABLE 5 PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 57
TABLE 6 PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 58
TABLE 7 STANDARD PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 59
TABLE 8 STANDARD PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS) 59
TABLE 9 SAFETY PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 60
TABLE 10 SAFETY PEN NEEDLES MARKET, BY REGION, 2016–2023 (THOUSAND UNITS) 61
TABLE 11 PEN NEEDLES MARKET, BY LENGTH, 2016–2023 (USD MILLION) 63
TABLE 12 4MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 64
TABLE 13 5MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 64
TABLE 14 6MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 65
TABLE 15 8MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 66
TABLE 16 10MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 66
TABLE 17 12MM PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 67
TABLE 18 PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION) 69
TABLE 19 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY REGION,
2016–2023 (USD MILLION) 70
TABLE 20 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY REGION,
2016–2023 (USD MILLION) 72
TABLE 21 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY,
BY REGION, 2016–2023 (USD MILLION) 73
TABLE 22 PEN NEEDLES MARKET FOR OTHER THERAPIES, BY REGION,
2016–2023 (USD MILLION) 74
TABLE 23 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2016–2023 (USD MILLION) 76
TABLE 24 PEN NEEDLES MARKET FOR RETAIL PURCHASES, BY REGION,
2016–2023 (USD MILLION) 77
TABLE 25 INDICATIVE LIST OF REGULATORY ACTS 78
TABLE 26 PEN NEEDLES MARKET FOR NON-RETAIL PURCHASES, BY REGION,
2016–2023 (USD MILLION) 79
TABLE 27 PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 82
TABLE 28 PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS) 82
TABLE 29 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 84
TABLE 30 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (MILLION UNITS) 84
TABLE 31 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 84
TABLE 32 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 85
TABLE 33 EUROPE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016–2023 (USD MILLION) 85
TABLE 34 EUROPE: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION) 85
TABLE 35 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION) 86
TABLE 36 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 86
TABLE 37 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 87
TABLE 38 UK: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 87
TABLE 39 UK: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 88
TABLE 40 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 88
TABLE 41 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 89
TABLE 42 ITALY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 89
TABLE 43 ITALY: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 90
TABLE 44 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 90
TABLE 45 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 91
TABLE 46 ROE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 91
TABLE 47 ROE: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 91
TABLE 48 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 93
TABLE 49 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2016–2023 (MILLION UNITS) 93
TABLE 50 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 93
TABLE 51 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 94
TABLE 52 NORTH AMERICA: PEN NEEDLES MARKET, BY NEEDLE LENGTH,
2016–2023 (USD MILLION) 94
TABLE 53 NORTH AMERICA: PEN NEEDLES MARKET, BY THERAPY,
2016–2023 (USD MILLION) 94
TABLE 54 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION) 95
TABLE 55 US: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 96
TABLE 56 US: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 96
TABLE 57 CANADA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 97
TABLE 58 CANADA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 97
TABLE 59 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 60 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2016–2023 (MILLION UNITS) 99
TABLE 61 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 99
TABLE 62 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 100
TABLE 63 ASIA PACIFIC: PEN NEEDLES MARKET, BY NEEDLE LENGTH,
2016–2023 (USD MILLION) 100
TABLE 64 ASIA PACIFIC: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION) 100
TABLE 65 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION) 101
TABLE 66 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 101
TABLE 67 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 102
TABLE 68 CHINA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 102
TABLE 69 CHINA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 103
TABLE 70 INDIA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 103
TABLE 71 INDIA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (MILLION UNITS) 104
TABLE 72 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 104
TABLE 73 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (THOUSAND UNITS) 104
TABLE 74 ROW: PEN NEEDLES MARKET, BY REGION, 2016–2023 (USD MILLION) 106
TABLE 75 ROW: PEN NEEDLES MARKET, BY REGION, 2016–2023 (MILLION UNITS) 106
TABLE 76 ROW: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 106
TABLE 77 ROW: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (THOUSAND UNITS) 107
TABLE 78 ROW: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016–2023 (USD MILLION) 107
TABLE 79 ROW: PEN NEEDLES MARKET, BY THERAPY, 2016–2023 (USD MILLION) 107
TABLE 80 ROW: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2016–2023 (USD MILLION) 108
TABLE 81 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016–2023 (USD MILLION) 108
TABLE 82 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (THOUSAND UNITS) 109
TABLE 83 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (USD MILLION) 109
TABLE 84 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE,
2016–2023 (THOUSAND UNITS) 110
TABLE 85 PRODUCT LAUNCHES 115
TABLE 86 EXPANSIONS 116
TABLE 87 AGREEMENTS 116


LIST OF FIGURES

FIGURE 1 PEN NEEDLES MARKET SEGMENTATION 16
FIGURE 2 PEN NEEDLES MARKET: RESEARCH METHODOLOGY 18
FIGURE 3 RESEARCH DESIGN 19
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 22
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 24
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 24
FIGURE 7 DATA TRIANGULATION METHODOLOGY 25
FIGURE 8 PEN NEEDLES MARKET, BY TYPE, 2018 27
FIGURE 9 PEN NEEDLES MARKET, BY LENGTH, 2018–2023 28
FIGURE 10 PEN NEEDLES MARKET, BY THERAPY, 2018–2023 28
FIGURE 11 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2018 29
FIGURE 12 GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET, 2018 30
FIGURE 13 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET 31
FIGURE 14 STANDARD PEN NEEDLES TO DOMINATE THE EUROPEAN PEN NEEDLES MARKET DURING THE FORECAST PERIOD 32
FIGURE 15 STANDARD PEN NEEDLES TO DOMINATE THE NORTH AMERICAN PEN NEEDLES MARKET DURING THE FORECAST PERIOD 33
FIGURE 16 ASIA PACIFIC IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 34
FIGURE 17 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 35
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS: PEN NEEDLES MARKET 39
FIGURE 19 SCORING METHODOLOGY 43
FIGURE 20 COMPARISONS OF COMPETITIVE INTENSITY SCORES: BD, NOVO NORDISK,
AND YPSOMED 49
FIGURE 21 RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND PEN NEEDLE FOCUS 50
FIGURE 22 SAFETY PEN NEEDLES BY BD AND STANDARD PEN NEEDLES BY NOVO NORDISK ARE PREMIUM-PRICED 51
FIGURE 23 BD HAS A ROBUST PORTFOLIO OF BOTH STANDARD AND SAFETY PEN NEEDLES 51
FIGURE 24 BD HAS A HIGHER FOCUS ON INNOVATION FOR ITS PEN NEEDLES BUSINESS 52
FIGURE 25 BD AND NOVO NORDISK HAVE A STRONG GEOGRAPHIC PRESENCE 53
FIGURE 26 BD AND NOVO NORDISK SHOWCASE HIGH FOCUS ON MARKETING & PROMOTIONAL ACTIVITIES 53
FIGURE 27 NOVO NORDISK HAS A HIGH FOCUS ON DIABETES EDUCATION & AWARENESS 54
FIGURE 28 NOVO NORDISK AGGRESSIVELY FOLLOWS THE STRATEGIES OF PARTNERSHIPS & AGREEMENTS 54
FIGURE 29 BD, NOVO NORDISK, AND YPSOMED EQUALLY EXHIBIT HIGH COMPLIANCE WITH INDUSTRY STANDARDS 55
FIGURE 30 STANDARD PEN NEEDLES TO COMMAND THE LARGEST SHARE OF THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 57
FIGURE 31 8MM PEN NEEDLES SEGMENT ACCOUNTED FOR THE LARGEST MARKET
SHARE IN 2018 63
FIGURE 32 INSULIN THERAPY SEGMENT TO COMMAND THE LARGEST SHARE OF THE PEN NEEDLES MARKET IN 2018 69
FIGURE 33 RETAIL SEGMENT WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 76
FIGURE 34 EUROPE TO COMMAND THE LARGEST SHARE OF THE GLOBAL PEN NEEDLES MARKET IN 2018 81
FIGURE 35 EUROPE: PEN NEEDLES MARKET SNAPSHOT 83
FIGURE 36 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT 92
FIGURE 37 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT 98
FIGURE 38 REST OF WORLD: PEN NEEDLES MARKET SNAPSHOT 105
FIGURE 39 PEN NEEDLES MARKET SHARE (AS OF 2017) 111
FIGURE 40 MNM DIVE-VENDOR COMPARISON MATRIX: PEN NEEDLES MARKET 114
FIGURE 41 STRATEGIES ADOPTED BY MARKET PLAYERS (2015-2018) 115
FIGURE 42 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 117
FIGURE 43 NOVO NORDISK: COMPANY SNAPSHOT 119
FIGURE 44 YPSOMED: COMPANY SNAPSHOT 121
FIGURE 45 B.BRAUN: COMPANY SNAPSHOT 125
FIGURE 46 TERUMO: COMPANY SNAPSHOT 126


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。